Headlands Technologies’s Fresenius Medical Care FMS Stock Holding History

Headlands Technologies’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-115	Closed	-$2K	–	588
2022 Q4	$2K	Buy	+115	New	+$1.71K	﹤0.01%	443

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Headlands Technologies's FMS Position: Q1 2023 in Review

Headlands Technologies sold out of Fresenius Medical Care (FMS) in Q1 2023, closing a stake of 115 shares — an estimated $2K sold.

Headlands Technologies first reported a position in FMS in Q4 2022 and held it in 1 quarter. The position peaked at $2K in Q4 2022. 155 funds tracked by Wall St. Rank hold FMS as of Q1 2023.

Headlands Technologies reported no remaining Fresenius Medical Care position as of Q1 2023 after selling out during the quarter.
Headlands Technologies sold 115 Fresenius Medical Care shares in Q1 2023, an estimated $2K.
Headlands Technologies first reported a position in Fresenius Medical Care in Q4 2022 and held it in 1 quarter.
Headlands Technologies's Fresenius Medical Care position peaked at $2K in Q4 2022.
155 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2023.

Based on Headlands Technologies's 13F filing for Q1 2023, filed 1 May 2023.